Literature DB >> 15684737

Toll-like receptor 2 stimulation decreases IFN-gamma receptor expression in mouse RAW264.7 macrophages.

Heather Curry1, Gail R Alvarez, Bruces S Zwilling, William P Lafuse.   

Abstract

Interferon-gamma (IFN-gamma) is a key cytokine in the immune defense against mycobacteria. IFN-gamma activates macrophages to resist the growth of mycobacteria and induces expression of MHC class II molecules required for antigen presentation. Macrophages infected with mycobacteria or stimulated by the interaction of mycobacterial products with toll-like receptor 2 (TLR2) have reduced responses to IFN-gamma. Previous research has shown that infection of mouse macrophages with Mycobacterium avium causes decreased expression of the IFN-gamma receptor (IFNGR). In the present study, we show that TLR2 stimulation of RAW264.7 macrophages with a synthetic lipoprotein, Pam3CSK4, also causes rapid decrease in expression of IFNGR-1 protein, with little change in IFNGR-2 protein levels. The decrease in IFNGR-2 expression in TLR2-stimulated cells required receptor internalization and proteasomal degradation. The level of IFNGR-1 mRNA also decreased in TLR2-stimulated RAW264.7 cells and M. avium-infected cells. The decrease in IFNGR-1 mRNA was shown to be due to decreased transcription. In spite of the decrease in IFNGR-2 receptor expression, activation of Stat1 activation by an optimal dose of IFN-gamma was identical between control and TLR2-stimulated RAW264.7 cells. However, at low suboptimal doses of IFN-gamma, Stat1 activation was decreased in TLR2-stimulated cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15684737     DOI: 10.1089/jir.2004.24.699

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  8 in total

1.  Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.

Authors:  Matthew J Kan; Jennifer E Lee; Joan G Wilson; Angela L Everhart; Candice M Brown; Andrew N Hoofnagle; Marilyn Jansen; Michael P Vitek; Michael D Gunn; Carol A Colton
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

2.  Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism.

Authors:  Amit Singhal; Anand Jaiswal; Virendra K Arora; Hanumanthappa K Prasad
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

3.  Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum.

Authors:  Uta Bussmeyer; Arup Sarkar; Kirsten Broszat; Tanja Lüdemann; Sonja Möller; Ger van Zandbergen; Christian Bogdan; Martina Behnen; J Stephen Dumler; Friederike D von Loewenich; Werner Solbach; Tamás Laskay
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

4.  Post-translational modification of the interferon-gamma receptor alters its stability and signaling.

Authors:  James D Londino; Dexter L Gulick; Travis B Lear; Tomeka L Suber; Nathaniel M Weathington; Luke S Masa; Bill B Chen; Rama K Mallampalli
Journal:  Biochem J       Date:  2017-10-10       Impact factor: 3.857

5.  β-Lactam Antibiotics Enhance the Pathogenicity of Methicillin-Resistant Staphylococcus aureus via SarA-Controlled Lipoprotein-Like Cluster Expression.

Authors:  Weilong Shang; Yifan Rao; Ying Zheng; Yi Yang; Qiwen Hu; Zhen Hu; Jizhen Yuan; Huagang Peng; Kun Xiong; Li Tan; Shu Li; Junmin Zhu; Ming Li; Xiaomei Hu; Xuhu Mao; Xiancai Rao
Journal:  mBio       Date:  2019-06-11       Impact factor: 7.867

Review 6.  The interferons and their receptors--distribution and regulation.

Authors:  Nicole A de Weerd; Thao Nguyen
Journal:  Immunol Cell Biol       Date:  2012-03-13       Impact factor: 5.126

7.  Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta.

Authors:  Juan C Salazar; Star Duhnam-Ems; Carson La Vake; Adriana R Cruz; Meagan W Moore; Melissa J Caimano; Leonor Velez-Climent; Jonathan Shupe; Winfried Krueger; Justin D Radolf
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

8.  TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production.

Authors:  Finlay W McNab; John Ewbank; Ricardo Rajsbaum; Evangelos Stavropoulos; Anna Martirosyan; Paul S Redford; Xuemei Wu; Christine M Graham; Margarida Saraiva; Philip Tsichlis; Damien Chaussabel; Steven C Ley; Anne O'Garra
Journal:  J Immunol       Date:  2013-07-10       Impact factor: 5.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.